2026-06-11
In the laboratory R&D of biopharmaceuticals and life sciences, the powder preparation of biological macromolecules such as proteins, enzyme preparations, and immune products is highly challenging. The secondary and tertiary structures of these active substances are extremely sensitive to heat. In traditional drying processes, minor temperature fluctuations in the hot air system—especially the "temperature overshoot" during the initial heating phase—often lead directly to protein denaturation, enzyme inactivation, or sample surface caking.
For R&D personnel, inconsistency across multiple experimental batches is frequently rooted in crude temperature control systems. Therefore, introducing high-precision, agile constant temperature control technology in micro-scale spray drying serves as the critical cornerstone for the standardized preparation of biological products.
To overcome this process pain point, the new generation of laboratory micro-scale spray dryers fully adopts real-time regulated PID constant temperature control technology. This technology achieves closed-loop micro-adjustments of heating power through dynamic mathematical models based on Proportional, Integral, and Derivative actions.
In actual equipment operation, the inlet air temperature can be flexibly set within the working range of 30℃ to 300℃ based on material characteristics. Relying on the PID control algorithm, the system compensates or reduces heater energy at millisecond frequencies, strictly locking the heating control precision within ±1℃.
This exceptionally high thermal field stability effectively eliminates the local hotspots caused by violent temperature fluctuations in traditional equipment, thereby protecting the molecular spatial conformation of proteins and enzyme preparations from damage at the source.
The physical advantages of PID temperature control technology ultimately translate into quality advantages for the final product. In synergy with the overall fluid dynamics design of the equipment, it directly determines the physical properties of the dried powder.
Liquid biological samples are fed into the system by a peristaltic pump and micronized through a high-precision SUS316L stainless steel two-fluid atomization nozzle. In a stable flow field featuring a maximum air volume of 5.6m³/min and a maximum air pressure of 1020Pa, the atomized droplets make contact with the constant-temperature hot air.
Because the temperature field is highly constant and uniform, the droplets undergo instantaneous heating and phase-change drying within an ultra-short 1.0 to 1.5 seconds. Moisture vaporization carries away most of the heat, maintaining a stable outlet air temperature of 80℃ to 90℃. This highly controlled process ensures that the particle size of the final collected powder follows a standard normal distribution. The powder particles exhibit no wall-sticking or agglomeration and possess excellent fluidity, enabling physicochemical parameters and biological activities to show high consistency across different batches, even for micro-scale experiments as small as 50 mL.
From an industry perspective, the R&D of cutting-edge biopharmaceuticals, such as proteins and enzyme preparations, requires not only equipment with visual monitoring capabilities (via high borosilicate glass drying chambers) but also imposes stringent requirements on the controllability of process parameters.
By relying on ±1℃ PID constant temperature control technology, the laboratory micro-scale spray dryer (maximum feed rate 2000 mL/H) has successfully transformed crude, empirical drying into a precise, digital process. The popularization of this technology is significantly reducing data variance during the sample trial-and-error phase for biopharmaceutical enterprises and university research institutions, establishing a firm technological foundation for high-standard reproducibility studies of biological products.
Send your inquiry directly to us